NCT00959881View on ClinicalTrials.gov

Study Evaluating The Coadministration of Begacestat And Donepezil

PHASE1CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Healthy Subjects
Interventions
DRUG

Donepezil plus placebo

5- and 10-mg tablets, single dose

DRUG

Donepezil

5- and 10-mg tablets, single dose

DRUG

Begacestat

6 x 50-mg capsules, single dose

Trial Locations (1)

66211

Pfizer Investigational Site, Overland Park

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00959881 - Study Evaluating The Coadministration of Begacestat And Donepezil | Biotech Hunter | Biotech Hunter